Insulin Inertia Among People With Type 2 Diabetes Mellitus in Qatar: The INERT-Q Study.

Mohammed BashirNoora Al ThaniAbeer KhalidObada KhalilZaina AlamerMohammad Khair HamadGowri KaruppasamyMohammed AbufaeidMutwakil ElbidairiDhabia Al-MohnnadiTarik ElhaddMahmoud Zirie

Published in: Endocrinology, diabetes & metabolism (2024)

In people with DM-2, there was an alarming delay in starting and titrating insulin. The reduction in HBA1c plateaued at 6th month. Earlier initiation and intensification of insulin therapy are critical to achieving glycaemic targets. More studies are needed to examine the causes of therapeutic inertia from physicians', patients' and systems' points of view.

Keyphrases

type diabetes
glycemic control
end stage renal disease
ejection fraction
newly diagnosed
primary care
chronic kidney disease
peritoneal dialysis
prognostic factors
stem cells
insulin resistance